onr:"swepub:oai:DiVA.org:umu-10379"
Search: onr:"swepub:oai:DiVA.org:umu-10379" > Conjugated estrogen...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Ödmark, Inga-Stina,1948-Umeå universitet,Obstetrik och gynekologi (author)
Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women : effects on carbohydrate metabolism and serum sex hormone-binding globulin
- Article/chapterEnglish2006
Publisher, publication year, extent ...
- Elsevier BV,2006
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:umu-10379
- https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-10379URI
- https://doi.org/10.1016/j.maturitas.2005.03.003DOI
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-26514URI
- http://kipublications.ki.se/Default.aspx?queryparsed=id:1927445URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Objective: To study the effects of different types of continuous hormone replacement therapy on carbohydrate metabolism. Method: Postmenopausal women were treated with conjugated estrogens, 0.625 mg/medroxyprogesterone acetate, 2.5 or 5mg (CEE/MPA) or tibolone 2.5 mg daily for 13 28-day cycles. Serum glucose and insulin were measured before and during a 75 g oral glucose tolerance test (OGTT) at baseline and after 3, 6 and 13 cycles and areas under the curve (AUC) were calculated. Sex hormone-binding globulin (SHBG) was measured as an additional marker of nutritional and insulin status. Results: Neither CEE/MPA2.5 mg nor tibolone had any effects on carbohydrate metabolism whileAUCinsulin, AUCglucose and also body mass index (BMI) increased after 13 cycles of treatment in the CEE/MPA 5 mg group. SHBG increased significantly during CEE/MPA treatment and decreased significantly during treatment with tibolone. The effects on SHBG were less pronounced in the CEE/MPA 5 mg group. Pretreatment SHBG showed significant negative correlations to BMI and to variables that may reflect a certain degree of insulin resistance, the most pronounced being fasting glucose. Changes in SHBG during treatment with tibolone were negatively correlated to pretreatment SHBG and positively to BMI, AUCinsulin and fasting insulin resistance index, while no such correlations were found in the CEE/MPA groups. There were no correlations between changes in AUCinsulin and AUCglucose on one hand and basal variables or treatment SHBG on the other in the CEE/MPA groups. Conclusion: The effects of tibolone and CEE/MPA on carbohydrate metabolism were considered to have clinical significance only for CEE/MPA 5 mg, indicating a less favourable role of the higher progestagen dose. The results further support the important role of metabolic and insulin status in the physiological regulation of SHBG and also indicate that the suppressive effect of tibolone on circulating SHBG is mainly depends on pretreatment SHBG levels. SHBG does not reflect changes in carbohydrate metabolism during CEE/MPA treatment.
Subject headings and genre
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Reproduktionsmedicin och gynekologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Obstetrics, Gynaecology and Reproductive Medicine hsv//eng
- aged
- carbohydrate metabolism/*drug effects
- enzyme-linked immunosorbent assay
- Estrogen Receptor Modulators/administration & dosage/*pharmacology
- Estrogen Replacement Therapy/methods
- Estrogens; Conjugated (USP)/administration & dosage/*pharmacology
- Female
- Humans
- Medroxyprogesterone 17-Acetate/administration & dosage/*pharmacology
- Middle Aged
- Norpregnenes/administration & dosage/*pharmacology
- Postmenopause
- Prospective Studies
- Regression Analysis
- Sex Hormone-Binding Globulin/*drug effects
- Sweden
- Obstetrics and gynaecology
- Obstetrik och gynekologi
- obstetrik och gynekologi
- Obstetrics and Gynaecology
Added entries (persons, corporate bodies, meetings, titles ...)
- Carlström, KjellKarolinska Institutet (author)
- Jonsson, BjörnUppsala universitet,Institutionen för kvinnors och barns hälsa,Barnendokrinologisk forskning/Tuvemo (author)
- Jonasson, Aino FianuKarolinska Institutet (author)
- Umeå universitetObstetrik och gynekologi (creator_code:org_t)
Related titles
- In:Maturitas: Elsevier BV53:1, s. 89-960378-51221873-4111
Internet link
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15964160&dopt=CitationPubMed
- https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-10379
- https://doi.org/10.1016/j.maturitas.2005.03.003
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-26514
- http://kipublications.ki.se/Default.aspx?queryparsed=id:1927445
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Ödmark, Inga-Sti ...
- Carlström, Kjell
- Jonsson, Björn
- Jonasson, Aino F ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Obstetrics Gynae ...
- Articles in the publication
- Maturitas
- By the university
- Umeå University
- Uppsala University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
